4//SEC Filing
Ruth Matthew R. 4
Accession 0001385508-22-000009
CIK 0001385508other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:16 PM ET
Size
5.1 KB
Accession
0001385508-22-000009
Insider Transaction Report
Form 4
Ruth Matthew R.
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-04+12,000→ 29,000 total
Footnotes (1)
- [F1]12,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-third of the RSUs vest on the anniversary dates of January 4, 2023, January 4, 2024 and January 4, 2025, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001872022
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:16 PM ET
- Size
- 5.1 KB